Clinical Trial Update: TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA [Phase 4]

View source ↗

Summary

A Phase 4 trial compares tenofovir disoproxil fumarate (TDF) with lamivudine plus adefovir in lamivudine- and adefovir-treated chronic hepatitis B patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)
• Lamivudine (lamivudine)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Keimyung University Dongsan Medical Center | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED